Comorbidity and related costs as a burden in the treatment of outpatients with depressive disorders in a primary care setting;Comorbilidad y coste ambulatorio asociado a los pacientes con trastornos depresivos en un ámbito poblacional

Farmacia Hospitalaria

Volumn 31, Issue 2, 2007, Pages 101-105

  Sicras Mainar, Antoni ^a,e   Navarro Artieda, R ^a   Rejas Gutierrez J ^b   Blanca Tamayo, M ^c   Serrat Tarres J ^d   Llopart Lopez J R ^a  

^a Direccion de Planificacion   (Spain)

^b PFIZER INC   (United States)

^c Centro de Psiquiatría   (Spain)

^d Serveis Assistencials   (Spain)

^e Direccion de Planificacion Y Desarrollo Organizativo   (Spain)

Author keywords

Costs; Depressive disorders; Primary care setting

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; CLINICAL RESEARCH; COMORBIDITY; CONFIDENCE INTERVAL; DEPRESSION; DIAGNOSTIC TEST; FEMALE; HEALTH CARE COST; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROLOGIC DISEASE; OUTPATIENT; PATIENT ASSESSMENT; PHYSICIAN; PREVALENCE; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY;

EID: 34347355586     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(07)75720-3     Document Type: Article

References (10)

1. Thomas MR, Waxmonsky JA, Gabow PA, Flanders-McGinnis G, Socherman R, Rost K. Prevalence of psychiatric disorders and costs of care among adult enrollees in a medicaid HMO. Psychiatr Serv 2005; 56: 1394-401.
2. Takahashi M, Tanaka K, Miyaoka H. Depression and associated factors of informal caregivers versus professional caregivers of demented patients. Psychiatry Clin Neurosci 2005; 59: 473-80.
3. Simon GE, Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv 1999; 50: 1303-8.
4. Shvartzman P, Weiner Z, Vardy D, Friger M, Sherf M, Biderman A. Health services utilization by depressive patients identified by the MINI questionnaire in a primary care setting. Scand J Prim Health Care 2005; 23: 18-25.
5. Iqbal SU, Prashker M. Pharmacoeconomic evaluation of antidepressants: a critical appraisal of methods. Pharmacoeconomics 2005; 23: 595-606.
6. Conde V, Franch JL. Escalas de evaluación comportamental para la cuantificación de la sintomatología psicopatológica en los trastornos angustiosos y depresivos. Departamento de psicología médica y de psiquiatría del Hospital Clínico de la Facultad de Medicina de Valladolid; 1984.
7. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000; 320: 1197-200.
8. Ros S, Aguera L, Gandara J, E Rojo J, Pedro JM. Potentiation strategies for treatment-resistant depression. Acta Psychiatr Scand 2005; 112: 14-24.
9. Lynch FL, Hornbrook M, Clarke GN, Perrin N, Polen MR, O'Connor E, et al. Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry 2005; 62: 1241-8.
10. Alegría M, Frank R, McGuire T. Managed care and systems cost-effectiveness: treatment for depression. Med Care 2005; 43: 1225-33.